| Anand Kapadia, MD | |
|
2300 S 16th St, Lincoln, NE 68502-3704 | |
| (402) 475-1011 | |
| Not Available |
| Full Name | Anand Kapadia |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 22 Years |
| Location | 2300 S 16th St, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235330358 | NPI | - | NPPES |
| 03037818500 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 24780 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryan Medical Center | Lincoln, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inpatient Physician Associates, Llc | 2365334364 | 76 |
News Archive
The best-known genetic variant linked to Alzheimer's disease may be "at work" promoting deposits of plaque in the brain long before any symptoms of the disease can be measured on tests, according to a national research study led by Indiana University School of Medicine investigators.
Health Care Management China today announced that Co-Founder and Vice Chairman Derek Muhs will present a keynote speech at the 6th annual Hospital Construction (HOSCON) Summit in New Delhi, India from September 3-4, 2015.
The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the EMEA's Committee for Orphan Medicinal Products (COMP) was handed down on last October 7th.
Squire, Sanders & Dempsey is launching Accountable Care Forum - From Volume to Value, a blog dedicated to analysis of the emerging accountable care organization landscape. The launch coincides with regulations issued today by the Centers for Medicare & Medicaid Services.
› Verified 7 days ago
| Entity Name | Inpatient Physician Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699725358 PECOS PAC ID: 2365334364 Enrollment ID: O20040325001149 |
News Archive
The best-known genetic variant linked to Alzheimer's disease may be "at work" promoting deposits of plaque in the brain long before any symptoms of the disease can be measured on tests, according to a national research study led by Indiana University School of Medicine investigators.
Health Care Management China today announced that Co-Founder and Vice Chairman Derek Muhs will present a keynote speech at the 6th annual Hospital Construction (HOSCON) Summit in New Delhi, India from September 3-4, 2015.
The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the EMEA's Committee for Orphan Medicinal Products (COMP) was handed down on last October 7th.
Squire, Sanders & Dempsey is launching Accountable Care Forum - From Volume to Value, a blog dedicated to analysis of the emerging accountable care organization landscape. The launch coincides with regulations issued today by the Centers for Medicare & Medicaid Services.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anand Kapadia, MD Po Box 6971, Lincoln, NE 68506-0971 Ph: (402) 486-7033 | Anand Kapadia, MD 2300 S 16th St, Lincoln, NE 68502-3704 Ph: (402) 475-1011 |
News Archive
The best-known genetic variant linked to Alzheimer's disease may be "at work" promoting deposits of plaque in the brain long before any symptoms of the disease can be measured on tests, according to a national research study led by Indiana University School of Medicine investigators.
Health Care Management China today announced that Co-Founder and Vice Chairman Derek Muhs will present a keynote speech at the 6th annual Hospital Construction (HOSCON) Summit in New Delhi, India from September 3-4, 2015.
The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the EMEA's Committee for Orphan Medicinal Products (COMP) was handed down on last October 7th.
Squire, Sanders & Dempsey is launching Accountable Care Forum - From Volume to Value, a blog dedicated to analysis of the emerging accountable care organization landscape. The launch coincides with regulations issued today by the Centers for Medicare & Medicaid Services.
› Verified 7 days ago
Quinn Nathaniel Willet, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-475-1011 Fax: 402-481-8805 | |
Dr. Alissa Marie Clough, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 024-818-5664 Fax: 024-818-8054 | |
Asha R Schweitzer, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-8566 Fax: 402-481-8805 | |
Nicole Lee Anderson Ericksen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-8566 Fax: 402-481-8805 | |
Maluk Singh Sidhu, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-475-1011 Fax: 402-481-5377 | |
Elizabeth A Friesen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-8566 Fax: 402-481-8805 |